Agomelatine for treatment of Obsessive-Compulsive Disorder
Phase 2
- Conditions
- Obsessive-compulsive disorder.Obsessive-compulsive disorder
- Registration Number
- IRCT20170123032145N5
- Lead Sponsor
- Iran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 44
Inclusion Criteria
Patients who meet DSM-5 criterion for OCD
Achieve more than 21 for Yale-Brown Obsessive Compulsive Scale
Age: 18-65 year old
Sign consent form
Exclusion Criteria
They should not be treated by any psychiatric intervention for last 6 weeks.
If they show any other important mental condition or suicidal thought, neurological deficit, will exclude from study.
They will be evaluated for cardiac, liver, kidney, pregnancy, lactation and mental retardation before entrance and any mentioned conditions will cause exclusion from study.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Severity of obsessive-compulsive disorder. Timepoint: Weeks: 0, 4, 8 and 12. Method of measurement: Yale-Brown Obsessive Compulsive Scale(YBOCS).
- Secondary Outcome Measures
Name Time Method